<?xml version="1.0" encoding="UTF-8"?>
<ref id="CIT0049">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Koshak</surname>
    <given-names>AE</given-names>
   </string-name>, 
   <string-name>
    <surname>Koshak</surname>
    <given-names>EA</given-names>
   </string-name>, 
   <string-name>
    <surname>Mobeireek</surname>
    <given-names>AF</given-names>
   </string-name>, 
   <string-name>
    <surname>Badawi</surname>
    <given-names>MA</given-names>
   </string-name>, 
   <string-name>
    <surname>Wali</surname>
    <given-names>SO</given-names>
   </string-name>, 
   <string-name>
    <surname>Malibary</surname>
    <given-names>HM</given-names>
   </string-name>, 
   <string-name>
    <surname>Atwah</surname>
    <given-names>AF</given-names>
   </string-name>, 
   <string-name>
    <surname>Alhamdan</surname>
    <given-names>MM</given-names>
   </string-name>, 
   <string-name>
    <surname>Almalki</surname>
    <given-names>RA</given-names>
   </string-name>, 
   <string-name>
    <surname>Madani</surname>
    <given-names>TA</given-names>
   </string-name>, 
   <etal>et al.</etal>
  </person-group>
  <year>2020</year>. 
  <article-title>Nigella sativa supplementation to treat symptomatic mild COVID-19: a structured summary of a protocol for a randomised, controlled, clinical trial</article-title>. 
  <source>Trials</source>. 
  <volume>21</volume>(
  <issue>1</issue>):
  <fpage>1</fpage>–
  <lpage>2</lpage>.
  <pub-id pub-id-type="pmid">31898511</pub-id>
 </mixed-citation>
</ref>
